logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Expert Review of Neurotherapeutics cover

Expert Review of Neurotherapeutics

IF3.4
Papers2309
Citations5668
Journal Papers 2620
Publication Date
delete
Comparing synthetic and biological therapy for the treatment of cluster headache: what is needed and when?
deleteExpert Review of Neurotherapeutics
IF3.4
delete2026-07-23
delete0
PREAI
deleteBrendan A. Parr; William B. Young; Stephen D. Silberstein
deleteShare
deleteSave
Innovation is not enough: lessons from lasmiditan for real-world effectiveness in acute migraine therapy
deleteExpert Review of Neurotherapeutics
IF3.4
delete2026-07-10
delete0
deleteOAAI
deleteSimona Guerzoni; Lanfranco Pellesi
deleteShare
deleteSave
Can the integration of blood-based biomarkers into Alzheimer’s disease diagnosis revolutionize the field?
deleteExpert Review of Neurotherapeutics
IF3.4
delete2026-07-07
delete0
PREAI
deleteLorenzo Gaetani; Giovanna Nardi; Lucilla Parnetti
deleteShare
deleteSave
Multiomics and proteomic insights into Alzheimer’s disease biology in Down syndrome
deleteExpert Review of Neurotherapeutics
IF3.4
delete2026-06-29
delete0
deleteOAAI
deleteMitchell Marta-Ariza; Thomas Wisniewski
deleteShare
deleteSave
Remote deep brain stimulation programming in childhood dystonia: opportunities, challenges, and future directions
deleteExpert Review of Neurotherapeutics
IF3.4
delete2026-06-29
delete0
PREAI
deleteRenato P. Munhoz; Ron Reitman; Daniel H. Johnston; Marcela Alicia Montiel; George M. Ibrahim; Carolina Gorodetsky
deleteShare
deleteSave
An overview of the safety and efficacy of sphenopalatine ganglion stimulation for the treatment of chronic cluster headache
deleteExpert Review of Neurotherapeutics
IF3.4
delete2026-06-28
delete0
deleteOAAI
deleteAmy Gimson; Nasia Christou; Fiona Greenwood; Stefania Maniataki; Peter J. Goadsby
deleteShare
deleteSave
The differential diagnosis of astrocytic neoplasms and its impact on treatment and prognosis
deleteExpert Review of Neurotherapeutics
IF3.4
delete2026-06-23
delete0
PREAI
deleteRob Dickerman; Mathew Mendoza; Makayla McClinton; Gwen Champion; Joneshia Runnels; Ha’nai Hudson
deleteShare
deleteSave
An update on the differential diagnosis of migraine in adults: when and how neuroimaging makes the difference
deleteExpert Review of Neurotherapeutics
IF3.4
delete2026-06-23
delete0
PREAI
deleteRoberta Messina; Alessandro Antoniazzi; Ilaria Cetta; Alessandro Visentini; Federica Genovese; Luca Consuma; Donato Conte; Massimo Filippi
deleteShare
deleteSave
Clinical efficacy of lacosamide in neuropathic pain: a systematic review of randomized controlled trials
deleteExpert Review of Neurotherapeutics
IF3.4
delete2026-06-22
delete0
PREAI
deleteGurleen Kaur; Chander Singh; Maryam Altuhafy; Junad Khan
deleteShare
deleteSave
Corticosteroids in withdrawal therapy following medication-overuse headache: a systematic review
deleteExpert Review of Neurotherapeutics
IF3.4
delete2026-06-22
delete0
PREAI
deleteEvelliny Gomes da Silva; Jonata Ribeiro de Sousa; Manuella Moraes Monteiro Barbosa Barros; Felipe Araújo Andrade de Oliveira; Pedro Augusto Sampaio Rocha-Filho
deleteShare
deleteSave
Fremanezumab for migraine in clinical practice: a systematic review and meta-analysis
deleteExpert Review of Neurotherapeutics
IF3.4
delete2026-06-14
delete0
PREAI
deleteJaime Fernández-Bravo-Rodrigo; Carlos Pascual-Morena; Alicia Saz-Lara; Irene Martínez-García; Carla Geovanna Lever-Megina; Silvana Patiño-Cardona; Amparo Flor-García; Iván Cavero-Redondo
deleteShare
deleteSave
Navigating long-acting antipsychotic decision-making in schizophrenia: clinical considerations and best practices
deleteExpert Review of Neurotherapeutics
IF3.4
delete2026-06-04
delete0
deleteOAAI
deleteJustin Faden; Leslie Citrome
deleteShare
deleteSave
STS101 nasal powder as a new treatment option for acute migraine with or without aura in adults
deleteExpert Review of Neurotherapeutics
IF3.4
delete2026-06-03
delete0
PREAI
deleteBradley Ong; Teshamae S. Monteith
deleteShare
deleteSave
A conceptual framework based on current and emerging treatments for treatment-resistant depression: mechanistic evolution, clinical evidence, and future directions
deleteExpert Review of Neurotherapeutics
IF3.4
delete2026-05-29
delete0
PREAI
deleteStephen Rush; Henry A. Nasrallah
deleteShare
deleteSave
Profiling galcanezumab in episodic migraine, cluster headache, and medication overuse headache
deleteExpert Review of Neurotherapeutics
IF3.4
delete2026-05-25
delete0
PREAI
deleteAbimael González-Hernández; José D. Ferrusca; Carlos M. Villalón
deleteShare
deleteSave
Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates: a plain language summary of publication
deleteExpert Review of Neurotherapeutics
IF3.4
delete2026-05-20
delete0
PREAI
deleteAsim Roy; Thomas Stern; John Harsh; Bruce C. Corser; Adrian Santamaria; Brian Abaluck; Sally Ibrahim; Katie Lancaster; Jennifer Gudeman
deleteShare
deleteSave
Evaluating nipocalimab for the treatment of chronic inflammatory demyelinating polyneuropathy
deleteExpert Review of Neurotherapeutics
IF3.4
delete2026-05-19
delete0
PREAI
deleteKazumoto Shibuya; Kazuaki Kito; Tomoki Suichi; Sonoko Misawa; Satoshi Kuwabara
deleteShare
deleteSave
Pain relief but at what cost: the need for suicidality screening during chronic pain management
deleteExpert Review of Neurotherapeutics
IF3.4
delete2026-05-15
delete0
deleteOAAI
deleteAleksandar Sic; Nebojsa Nick Knezevic
deleteShare
deleteSave
How are interleukin-6 receptor antagonists shaping the future of neuromyelitis optica spectrum disorder?
deleteExpert Review of Neurotherapeutics
IF3.4
delete2026-05-06
delete0
deleteOAAI
deleteMurat Kürtüncü
deleteShare
deleteSave
Treating the root cause of tension-type headache: when analgesics address the symptom but not the disorder
deleteExpert Review of Neurotherapeutics
IF3.4
delete2026-05-05
delete0
deleteOAAI
deleteModar Khalil; Fayyaz Ahmed
deleteShare
deleteSave